Pharma wrap: Why India should consider extension of interval between two doses of Covishield vaccine

"In exploratory analyses, a single standard dose of ChAdOx1 nCoV-19 had an efficacy of 76 percent against symptomatic COVD-19 in the first 90 days after vaccination, with no significant waning of protection during this period," Lancet study said.

from Moneycontrol Business News https://ift.tt/2NH1O3v